colforsin has been researched along with Diabetes Mellitus, Type 2 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Li, Y; Liu, J; Ma, W; Miranda, KM; Peng, S; Tian, J; Zhang, Y | 1 |
| Gholami Farashah, MS; Mohammadnejad, D; Naghibi, M; Soleimani Rad, J; Tayefi Nasrabadi, H | 1 |
| Ameneiro, C; Beiroa, D; Bernardo, G; Bilbao, J; Bravo, SB; Carneiro, C; Cho, JW; Coppari, R; Cuñarro, J; Da Silva Lima, N; Dieguez, C; Dp Chantada-Vazquez, M; Fernandez, U; Fernández-Ramos, D; Ferno, J; Fidalgo, M; Fondevila, MF; Fruhbeck, G; Garcia-Vence, M; Gonzalez-Rellan, MJ; Guallar, D; Herzig, S; Iglesias, C; López, M; Lopitz-Otsoa, F; Martinez-Chantar, ML; Mato, JM; Millet, O; Müller, TD; Nogueiras, R; Novoa, E; Perez-Fernandez, R; Porteiro, B; Rodríguez, A; Sabio, G; Senra, A; Seoane, S; Tovar, S; Varela-Rey, M; Veyrat-Durebex, C; Vidal, A; Woodhoo, A; Yang, WH | 1 |
| Bernlohr, DA; Billington, CJ; Connett, JC; Foncea, R; Hertzel, AV; Ikramuddin, S; Jahansouz, C; Jensen, M; Josephrajan, A; Kizy, S; Korner, J; Thomas, AJ; Xu, H | 1 |
| Balaz, M; Belan, V; Kurdiova, T; Maderova, D; Mayer, A; Ukropcova, B; Ukropec, J; Wolfrum, C | 1 |
| Bajpeyi, S; Covington, JD; Hebert, RC; Masinter, BS; Noland, RC; Ravussin, E; Rustan, AC; Smith, SR | 1 |
| Gusakova, SV; Kovalev, IV; Mangataeva, OS; Petrova, IV; Suslova, TE; Trubacheva, OA | 1 |
| Alm, P; Efendic, S; Guenifi, A; Henningsson, R; Jimenez-Feltström, J; Lundquist, I; Mosén, H; Ostenson, CG; Salehi, A | 1 |
| Cnop, M; Cunha, DA; Eizirik, DL; Gurzov, EN; Igoillo-Esteve, M; Ladrière, L; Lupi, R; Marchetti, P; Ortis, F | 1 |
| Molkentin, JD; Navedo, MF; Nieves-Cintrón, M; Santana, LF; Takeda, Y | 1 |
| Albarado, DC; Bajpeyi, S; Church, TS; Conley, KE; Costford, SR; Jubrias, SA; Pasarica, M; Smith, SR; Thomas, SC; Xie, H | 1 |
| Abdel-Halim, SM; Ahrén, B; Efendic, S; Ljungberg, O; Lukinius, A; Portela-Gomes, GM | 1 |
| Hatakeyama, H; Kasai, H; Kishimoto, T; Nemoto, T; Takahashi, N | 1 |
| Mühlbauer, E; Peschke, E; Stumpf, I | 1 |
| Abdel-Halim, SM; Berggren, PO; Efendić, S; Guenifi, A; Khan, A; Larsson, O; Ostenson, CG | 1 |
| Arner, P; Dauzats, M; Hellström, L; Langin, D; Reynisdottir, S | 1 |
| Leclercq-Meyer, V; Malaisse, WJ | 1 |
| Abdel-Halim, SM; Guenifi, A | 1 |
| Cerasi, E; Efendic, S; Kaiser, N; Khan, A; Nesher, R; Warwar, N | 1 |
| Absher, PM; Dunkerley, HA; Jimmo, SL; Maurice, DH; Netherton, SJ; Palmer, D; Raymond, DR; Russell, JC; Sage, EH; Tilley, DG; Vernon, RB | 1 |
| Houslay, MD; Palmer, TM; Taberner, PV | 1 |
| Connell, JM; Houslay, MD; Livingstone, C; McGregor, MA; McLellan, AR; Milligan, G; Paterson, KR; Small, M; Wilson, A | 1 |
3 trial(s) available for colforsin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical management.
Topics: Adjuvants, Immunologic; Biomarkers; Colforsin; Critical Care; Diabetes Mellitus, Type 2; Fatty Acid-Binding Proteins; Female; Follow-Up Studies; Gastric Bypass; Humans; Male; Middle Aged; Obesity; Risk Reduction Behavior; Treatment Outcome | 2019 |
Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
Topics: Adult; Carrier Proteins; Colforsin; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Humans; Lipid Metabolism; Male; Muscle Fibers, Skeletal; Muscle, Skeletal; Palmitic Acid; Perilipin-1; Phosphoproteins; Sedentary Behavior; Young Adult | 2015 |
Skeletal muscle NAMPT is induced by exercise in humans.
Topics: Adenosine Triphosphate; Adult; Cells, Cultured; Colforsin; Cross-Sectional Studies; Cytokines; Diabetes Mellitus, Type 2; Exercise; Exercise Therapy; Heat-Shock Proteins; Humans; Life Style; Middle Aged; Mitochondria; Muscle, Skeletal; Myoblasts; Nicotinamide Phosphoribosyltransferase; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Endurance; RNA, Messenger; Signal Transduction; Sports; Transcription Factors; Young Adult | 2010 |
19 other study(ies) available for colforsin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance.
Topics: Anti-Inflammatory Agents; Antioxidants; Aquaporin 2; Cells, Cultured; Coumaric Acids; Diabetes Mellitus, Type 2; Drug Design; Glucose Intolerance; Humans; Kidney Tubules, Collecting; Metabolic Syndrome; Microsomes, Liver; Nitric Oxide Donors; Rosiglitazone | 2019 |
The effects of metformin and forskolin on sperm quality parameters and sexual hormones in type II diabetic male rats.
Topics: Animals; bcl-2-Associated X Protein; Blood Glucose; Colforsin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Metformin; Proto-Oncogene Proteins c-bcl-2; Rats; Semen; Sperm Motility; Spermatozoa; Testosterone | 2022 |
O-GlcNAcylated p53 in the liver modulates hepatic glucose production.
Topics: Acetylglucosamine; Animals; Base Sequence; Caloric Restriction; Cell Line; Colforsin; Diabetes Mellitus, Type 2; Epinephrine; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Glycosylation; Hepatocytes; Humans; Hydrocortisone; Hyperglycemia; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Protein Binding; Protein Stability; Pyruvic Acid; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Protein p53 | 2021 |
Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes.
Topics: Cells, Cultured; Colforsin; Diabetes Mellitus, Type 2; Exercise; Fibronectins; Humans; Ionomycin; Muscle Fibers, Skeletal; Muscle, Skeletal; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Prediabetic State; RNA, Messenger; Transcription Factors | 2014 |
[THE INFLUENCE OF HYDROGEN SULFIDE ON COLLAGEN-INDUCED AGGREGATION OF HUMAN PLATELETS].
Topics: Adult; Blood Platelets; Calcium; Case-Control Studies; Colforsin; Collagen; Cyclic AMP; Diabetes Mellitus, Type 2; Female; Gasotransmitters; Glycosylation; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Oxidation-Reduction; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Primary Cell Culture; Protein Carbonylation; Sulfides | 2015 |
Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production.
Topics: Animals; Arginine; Colforsin; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Wistar | 2008 |
Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.
Topics: Animals; Antigens, Differentiation; Apoptosis; Blotting, Western; Cell Survival; Colforsin; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Endoplasmic Reticulum; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Heat-Shock Proteins; Hypoglycemic Agents; Insulin-Secreting Cells; Lipid Metabolism; Male; Peptides; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptors, Glucagon; Regulatory Factor X Transcription Factors; RNA Interference; Transcription Factors; Up-Regulation; Venoms | 2009 |
Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells.
Topics: A Kinase Anchor Proteins; Animals; Blood Glucose; Calcium Channels, L-Type; Calcium Signaling; Cerebral Arteries; Colforsin; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Membrane Potentials; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Kinase C-alpha; Protein Kinase Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Up-Regulation | 2010 |
PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets.
Topics: Animals; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucose; Humans; Immunohistochemistry; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Microscopy, Immunoelectron; Neuropeptides; Pancreas; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Wistar | 2003 |
Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets.
Topics: Animals; Calcium; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Exocytosis; Glucose; Image Cytometry; Insulin; Insulin Secretion; Intracellular Signaling Peptides and Proteins; Islets of Langerhans; Mice; Mice, Inbred ICR; Microscopy, Confocal; Potassium Channels; Thionucleotides | 2006 |
Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Brain; Cell Line, Tumor; Colforsin; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Guanylate Cyclase; Insulin; Insulin Secretion; Insulin-Secreting Cells; Insulinoma; Melatonin; Pineal Gland; Rats; Rats, Wistar; Receptor, Melatonin, MT2; Signal Transduction; Tetrahydronaphthalenes; Tryptamines | 2008 |
Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP.
Topics: Animals; Arginine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 2; Diazoxide; Exocytosis; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Membrane Potentials; Patch-Clamp Techniques; Rats; Rats, Mutant Strains; Reference Values | 1996 |
Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Topics: Adipocytes; Adrenergic beta-Agonists; Adult; Body Mass Index; Bucladesine; Clonidine; Colforsin; Diabetes Mellitus, Type 2; Dobutamine; Dose-Response Relationship, Drug; Female; Glycerol; Humans; Isoproterenol; Lipolysis; Male; Norepinephrine; Nuclear Family; Obesity; Pedigree; Receptors, Adrenergic, beta; RNA, Messenger; Sterol Esterase; Sympathomimetics; Terbutaline | 1996 |
Modulation of gliquidone action by forskolin in the pancreas of normal and GK rats.
Topics: Animals; Blood Glucose; Colforsin; Diabetes Mellitus, Type 2; Glucagon; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Perfusion; Rats; Rats, Inbred Strains; Rats, Wistar; Reference Values; Sulfonylurea Compounds; Time Factors | 1997 |
Glucose enhances adenylyl cyclase responses in normal but not diabetic GK rat islets.
Topics: Adenylyl Cyclases; Animals; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Glycosylation; Insulin; Insulin Secretion; Islets of Langerhans; Male; Rats | 2001 |
Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Topics: Animals; Colforsin; Diabetes Mellitus, Type 2; Diazoxide; Disease Models, Animal; Disease Susceptibility; Gerbillinae; Glucagon; Glucagon-Like Peptide 1; Glucose; Hyperglycemia; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Isoenzymes; Oxidation-Reduction; Peptide Fragments; Protein Kinase C; Protein Precursors; Rats; Rats, Sprague-Dawley; Reference Values; Signal Transduction; Tetradecanoylphorbol Acetate | 2001 |
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aorta; Cell Membrane; Cell Movement; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytosol; Diabetes Mellitus, Type 2; Hydrolysis; Muscle, Smooth, Vascular; Obesity; Phenotype; Phosphodiesterase Inhibitors; Quinolones; Rats; Rats, Mutant Strains | 2002 |
Alterations in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity.
Topics: Adenylyl Cyclases; Adipose Tissue; Animals; Cell Membrane; Cells, Cultured; Colforsin; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; GTP-Binding Proteins; Isoproterenol; Magnesium; Mice; Mice, Inbred CBA; Obesity; Secretin | 1992 |
Altered G-protein expression and adenylate cyclase activity in platelets of non-insulin-dependent diabetic (NIDDM) male subjects.
Topics: Adenylyl Cyclases; Alprostadil; Blood Platelets; Blotting, Western; Cell Membrane; Colforsin; Diabetes Mellitus, Type 2; Enzyme Activation; Epinephrine; GTP-Binding Proteins; Humans; Male; Signal Transduction | 1991 |